Shin Poong Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Shin Poong Pharmaceutical Co. Ltd.
DFA Emerging Markets Small Cap Series
286,037
0.54%
0
0.03%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
225,378
0.43%
0
0.01%
04/30/2018
RAM (Lux) Systematic Funds - Emerging Markets Equities
112,625
0.21%
112,625
0.03%
06/30/2017
Mirae Asset TIGER Health Care ETF
48,311
0.09%
9,371
0.22%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
13,211
0.03%
0
0.01%
12/31/2017
9,457
0.02%
5,054
0.03%
04/30/2018
DFA TA World (ex-US) Core Equity Portfolio
7,521
0.01%
0
0%
04/30/2018
John Hancock II - Emerging Markets Fund
5,185
0.01%
0
0%
04/30/2018
MGI Funds Plc - Emerging Markets Equity Fund
3,957
0.01%
0
0%
12/31/2017
Dimensional Funds Plc - Pacific Basin Small Companies Fund
3,732
0.01%
126
0.03%
11/30/2017
| Address |
7 Wonsi-ro
Ansan-si GY 15610
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.shinpoong.co.kr |
| Updated |
07/08/2019 |
| Shinpoong Pharmaceutical Co. Ltd. engages in the manufacture and sales of pharmaceutical products. Its products include joint function enhancers, antiinflammatory analgesic drugs, antibiotics, medicine for high blood pressure, and others. The company was founded on June 5, 1962 and is headquartered in Ansan-si, South Korea. |
